Indole antagonists of P2Y 1 receptor useful in the...

Details Indole antagonists of P2Y 1 receptor useful in the... Indole antagonists of P2Y 1 receptor useful in the...

2011-06-14

2011-06-14

Havlin, Robert (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S419000

Reexamination Certificate

active

07960569

ABSTRACT:
The present invention provides indole compounds of Formula (I) or (II):or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables ring A, X1, X2, X3, X4, R6, and R15are as defined herein. These compounds are selective inhibitors of the human P2Y1receptor which can be used as medicaments.

REFERENCES:
patent: 3118888 (1964-01-01), Giraldi et al.
patent: 3162644 (1964-12-01), Englisch et al.
patent: 4179563 (1979-12-01), Butler
patent: 4186199 (1980-01-01), Glamkowski et al.
patent: 4435391 (1984-03-01), Sasahara et al.
patent: 4663453 (1987-05-01), Glamkowski et al.
patent: 4840947 (1989-06-01), Glamkowski et al.
patent: 4886822 (1989-12-01), Shibuya et al.
patent: 5500424 (1996-03-01), Nagamine et al.
patent: 5547966 (1996-08-01), Atwal et al.
patent: 5612359 (1997-03-01), Murugesan
patent: 5708008 (1998-01-01), Audia et al.
patent: 5886004 (1999-03-01), Audia et al.
patent: 6020357 (2000-02-01), Pinto et al.
patent: 6043265 (2000-03-01), Murugesan et al.
patent: 6143764 (2000-11-01), Kubo et al.
patent: 6180675 (2001-01-01), Widdowson et al.
patent: 6187797 (2001-02-01), Pruitt et al.
patent: 6329395 (2001-12-01), Dugar et al.
patent: 6586453 (2003-07-01), Dhanoa et al.
patent: 6596746 (2003-07-01), Das et al.
patent: 6656933 (2003-12-01), Hickey
patent: 6825355 (2004-11-01), Das et al.
patent: 6863647 (2005-03-01), Pevarello et al.
patent: 2002/0077486 (2002-06-01), Scarborough et al.
patent: 2003/0061667 (2003-04-01), Lim et al.
patent: 2003/0065176 (2003-04-01), Kang et al.
patent: 2003/0153568 (2003-08-01), Cusack et al.
patent: 2003/0195232 (2003-10-01), Kawasaki et al.
patent: 2003/0207870 (2003-11-01), Dumas et al.
patent: 2003/0216396 (2003-11-01), Dumas et al.
patent: 2004/0023961 (2004-02-01), Dumas et al.
patent: 2004/0038992 (2004-02-01), Bemis et al.
patent: 2004/0102636 (2004-05-01), Miller et al.
patent: 2004/0209930 (2004-10-01), Carboni et al.
patent: 2004/0259875 (2004-12-01), Yura et al.
patent: 2005/0009815 (2005-01-01), DeVita et al.
patent: 2005/0012254 (2005-01-01), Hsu
patent: 2005/0119304 (2005-06-01), Yura et al.
patent: 2005/0203146 (2005-09-01), Herpin et al.
patent: 2005/0256161 (2005-11-01), Tempest et al.
patent: 2005/0261244 (2005-11-01), Tuerdi et al.
patent: 2005/0267119 (2005-12-01), Chao et al.
patent: 2006/0173002 (2006-08-01), Sutton et al.
patent: 2006/0293281 (2006-12-01), Qiao et al.
patent: 2006/0293336 (2006-12-01), Sutton et al.
patent: 2006/0293522 (2006-12-01), Sutton
patent: 2007/0004677 (2007-01-01), Chao et al.
patent: 0 028 489 (1981-05-01), None
patent: 0 129 692 (1985-01-01), None
patent: 0 265 734 (1988-05-01), None
patent: 0 286 979 (1988-10-01), None
patent: 0 638 557 (1995-02-01), None
patent: 1 120 409 (2001-08-01), None
patent: 1 123 918 (2001-08-01), None
patent: 1 402 888 (2004-03-01), None
patent: 1 661 879 (2006-05-01), None
patent: 1 712 242 (2006-10-01), None
patent: 1 342 550 (1962-12-01), None
patent: 56-167649 (1981-12-01), None
patent: 62-280847 (1987-12-01), None
patent: 3-39740 (1991-02-01), None
patent: 4-319958 (1992-11-01), None
patent: 7-101153 (1995-04-01), None
patent: 2001-89412 (2001-04-01), None
patent: WO 96/17825 (1996-06-01), None
patent: WO 97/29743 (1997-08-01), None
patent: WO 98/18430 (1998-05-01), None
patent: WO 98/37035 (1998-08-01), None
patent: WO 98/57951 (1998-12-01), None
patent: WO 99/31086 (1999-06-01), None
patent: WO 99/32463 (1999-07-01), None
patent: WO 00/01389 (2000-01-01), None
patent: WO 00/59506 (2000-10-01), None
patent: WO 00/76495 (2000-12-01), None
patent: WO 00/76970 (2000-12-01), None
patent: WO 01/23358 (2001-04-01), None
patent: WO 01/40231 (2001-06-01), None
patent: WO 01/47919 (2001-07-01), None
patent: WO 01/51490 (2001-07-01), None
patent: WO 01/55146 (2001-08-01), None
patent: WO 01/57008 (2001-08-01), None
patent: WO 01/72751 (2001-10-01), None
patent: WO 02/44145 (2002-06-01), None
patent: WO 02/064211 (2002-08-01), None
patent: WO 02/088090 (2002-11-01), None
patent: WO 02/090352 (2002-11-01), None
patent: WO 03/007955 (2003-01-01), None
patent: WO 03/013517 (2003-02-01), None
patent: WO 03/014064 (2003-02-01), None
patent: WO 03/026652 (2003-04-01), None
patent: WO 03/045920 (2003-06-01), None
patent: WO 03/055484 (2003-07-01), None
patent: WO 03/055848 (2003-07-01), None
patent: WO 03/080553 (2003-10-01), None
patent: WO 2004/002481 (2004-01-01), None
patent: WO 2004/012733 (2004-02-01), None
patent: WO 2004/022529 (2004-03-01), None
patent: WO 2004/046090 (2004-06-01), None
patent: WO 2004/060907 (2004-07-01), None
patent: WO 2004/085433 (2004-10-01), None
patent: WO 2004/110374 (2004-12-01), None
patent: WO 2005/037763 (2005-04-01), None
patent: WO 2005/042488 (2005-05-01), None
patent: WO 2005/063293 (2005-07-01), None
patent: WO 2005/070920 (2005-08-01), None
patent: WO2005/113537 (2005-12-01), None
patent: WO 2006/091963 (2006-08-01), None
Domschke et al. (CAPLUS Abstract of: Chemische Berichte (1960), 93, 2097-2106).
Kubinyi (3D QSAR in Drug Design: Ligand-Protein Interactions and Molecular Similarity, vol. 2-3, Springer, 1998, 800 pages) TOC and pp. 243-244 provided.
Pfefferkorn et al. (Bioorg. Med. Chem. Lett., 18 (2008) 3338-3343).
CAPLUS Abstract of: Vincente et al. (Organometallics (2005), 24(21), 5044-5057).
Abbracchio, M.P. et al., “Characterization of the UDP-glucose receptor (re-named here the P2Y14receptor) adds diversity to the P2Y receptor family”, Trends in Pharmacological Sciences, vol. 24, No. 2, pp. 52-55 (2003).
Abbracchio, M.P. et al., “Purinoceptors: Are There Families of P2X and P2Y Purinoceptors?”, Pharmac. Ther., vol. 64, pp. 445-475 (1994).
Atwal, K.S. et al., “Cardioselective Antiischemic ATP-Sensitive Potassium Channel Openers. 4. Structure-Activity Studies on Benzopyranylcyanoguanidines: Replacement of the Benzopyran Portion”, Journal of Medicinal Chemistry, vol. 39, No. 1, pp. 304-313 (1996).
Bareich, D.C. et al., “Simultaneous In Vitro Assay of the First Four Enzymes in the Fungal Aspartate Pathway Identifies a New Class of Aspartate Kinase Inhibitor”, Chemistry & Biology, vol. 10, pp. 967-973 (2003).
Baurand, A. et al., “The P2Y1Receptor as a Target for New Antithrombotic Drugs: A Review of the P2Y1Antagonist MRS-2179”, Cardiovascular Drug Reviews, vol. 21, No. 1, pp. 67-76 (2003).
Beaver, D.J. et al., “The Preparation and Bacteriostatic Activity of Substituted Ureas”, J. Am. Chem. Soc., vol. 79, pp. 1236-1245 (1957).
Bensemann, I. et al., “Creation of hydrogen bonded 1D networks by co-crystallization ofN,N′-bis(2-pyridyl)aryldiamines with dicarboxylic acids”, Org. Biomol. Chem., vol. 1, pp. 1425-1434 (2003).
Boeynaems, J.-M. et al., “Overview of P2Y Receptors as Therapeutic Targets”, Drug Development Research, vol. 52, pp. 187-189 (2001).
Bundgaard, H., Chapter 5: “Design and Application of Prodrugs”, A Textbook of Drug Design and Development, Harwood Academic Publishers, publ., Krogsgaard-Larsen, P. et al., eds., pp. 113-191 (1991).
Bundgaard, H., “Prodrugs as a means to improve the delivery of peptide drugs”, Advanced Drug Delivery Reviews, vol. 8, pp. 1-38 (1992).
Burnstock, G. et al., “P2 Purinergic Receptors: Modulation of Cell Function and Therapeutic Potential”, The Journal of Pharmacology and Experimental Therapeutics, vol. 295, No. 3, pp. 862-869 (2000).
Chan, D.M.T. et al., Chapter 5: “Recent Advances in Copper-promoted C-Heteroatom Bond Cross-coupling Reactions with Boronic Acids and Derivatives”, Boronic Acids: Preparation and Applications in Organic Synthesis and Medicine, Wiley-VCH Verlag GmbH & Co., publ., Hall, D.G., ed., pp. 205-240 (2005).
Chou, T.-C. et al., “Quantitative Analysis of Dose-Effect Relationships: The Combined Effects of Multiple Drugs or Enzyme Inhibitors”, Adv. Enzyme Regul., vol. 22, pp. 27-55 (1984).
Cobern, D. et al., “Some Newp-Chlorophenoxycarbanilides and Their Bacteriostatic Activities”, J. Med. Chem., vol. 11, pp. 163-16

Affiliated with

Also associated with

Rating

Indole antagonists of P2Y 1 receptor useful in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole antagonists of P2Y 1 receptor useful in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole antagonists of P2Y 1 receptor useful in the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2655182